搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 小时
Nothing About My Weight Gain Made Sense Until I Was Diagnosed With Insulin Resistance
After struggling with weight gain for three years, Sarah Bisacca was diagnosed with insulin resistance. Here's how she was learned to manage it.
2 小时
on MSN
Sen. Wiener introduces bills aimed at reducing the cost of prescription drugs
State Sen. Scott Wiener is rolling out new legislation meant to lower the cost of insulin and other prescription drugs in California.
3 小时
on MSN
Alison Hammond says she has not wanted to use medication for weight loss
Weight loss drugs have hit the headlines in the couple of years and a number of celebrities have spoken about using them.
4 小时
New task force looks to bring down prescription drug prices
A new task force met for the first time Wednesday with a goal of finding ways to lower prescription drug costs. Lawmakers ...
News Medical
5 小时
Childhood diabetes rates surge globally
Researchers investigate global trends in childhood diabetes rates and different factors that contribute to its incidence.
Health.com
8 小时
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to Experts
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...
9 小时
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
ABC Action News
9 小时
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
9 小时
Lilly's Head-To-Head Data Lands Blow On Novo In Battle For Weight Loss Supremacy
Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.
11 小时
Social media users falsely link diabetes and parasites
Diabetes occurs when the body cannot produce enough insulin to manage a person's blood sugar levels, and doctors treat it ...
11 小时
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
12 小时
Eli Lilly says Zepbound's weight-loss results beat those of rival Wegovy
Eli Lilly & Co. Inc.'s stock (LLY) rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk's Wegovy in a head-to-head study.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈